You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/112063
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBatista-Duharte, Alexander-
dc.contributor.authorPortuondo, Deivys-
dc.contributor.authorPerez, O.-
dc.contributor.authorCarlos, Iracilda Zeppone-
dc.date.accessioned2014-12-03T13:09:12Z-
dc.date.accessioned2016-10-25T20:10:20Z-
dc.date.available2014-12-03T13:09:12Z-
dc.date.available2016-10-25T20:10:20Z-
dc.date.issued2014-05-01-
dc.identifierhttp://dx.doi.org/10.1016/j.intimp.2014.02.033-
dc.identifier.citationInternational Immunopharmacology. Amsterdam: Elsevier Science Bv, v. 20, n. 1, p. 170-180, 2014.-
dc.identifier.issn1567-5769-
dc.identifier.urihttp://hdl.handle.net/11449/112063-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/112063-
dc.description.abstractVaccine safety is a topic of concern for the treated individual, the family, the health care personnel, and the others involved in vaccination programs as recipients or providers. Adjuvants are necessary components to warrant the efficacy of vaccines, however the overstimulation of the immune system is also associated with adverse effects. Local reactions are the most frequent manifestation of toxicity induced by adjuvanted vaccines and, with the exception of the acute phase response (APR), much less is known about the systemic reactions that follow vaccination. Their low frequency or subclinical expression meant that this matter has been neglected. In this review, various systemic reactions associated with immune stimulation will be addressed, including: APR, hypersensitivity, induction or worsening of autoimmune diseases, modification of hepatic metabolism and vascular leak syndrome (VLS), with an emphasis on the mechanism involved. Finally, the authors analyze the current focus of discussion about vaccine safety and opportunities to improve the design of new adjuvanted vaccines in the future. (C) 2014 Elsevier B.V. All rights reserved.en
dc.description.sponsorshipUNESP-
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)-
dc.format.extent170-180-
dc.language.isoeng-
dc.publisherElsevier B.V.-
dc.sourceWeb of Science-
dc.subjectSystemic reactionsen
dc.subjectAdjuvanten
dc.subjectVaccineen
dc.subjectImmunotoxicityen
dc.subjectAction mechanismsen
dc.titleSystemic immunotoxicity reactions induced by adjuvanted vaccinesen
dc.typeoutro-
dc.contributor.institutionMed Sci Univ-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.contributor.institutionCAPES PVE Brasil Grant-
dc.contributor.institutionUniv Med Sci Havana-
dc.description.affiliationMed Sci Univ, Toxicol & Biomed Ctr TOXIMED, Immunotoxicol Lab, Santiago De Cuba 90400, Cuba-
dc.description.affiliationUniv Estadual Paulista, UNESP, Fac Pharmaceut Sci, BR-14801902 Araraquara, SP, Brazil-
dc.description.affiliationCAPES PVE Brasil Grant, Foreigner Visiting Prof Program, Araraquara, Brazil-
dc.description.affiliationUniv Med Sci Havana, Inst Preclin & Basic Sci ICBP Victoria de Giron, Dept Immunol, Havana, Cuba-
dc.description.affiliationUnespUniv Estadual Paulista, UNESP, Fac Pharmaceut Sci, BR-14801902 Araraquara, SP, Brazil-
dc.identifier.doi10.1016/j.intimp.2014.02.033-
dc.identifier.wosWOS:000336337900023-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofInternational Immunopharmacology-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.